A semi-structured interview to assess visual hallucinations in older people

International Journal of Geriatric Psychiatry

Volumn 23, Issue 7, 2008, Pages 712-718

  Mosimann, Urs Peter ^a   Collerton, Daniel ^b   Dudley, Robert ^b   Meyer, Thomas Daniel ^b   Graham, Gemma ^c   Dean, Jennifer Louise ^b   Bearn, Daniel ^a   Killen, Alison ^a   Dickinson, Lucy ^a   Clarke, Mike Patrick ^a   McKeith, Ian Grant ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c TEESSIDE UNIVERSITY   (United Kingdom)

Author keywords

Assessment; Charles Bonnet syndrome; Lewy body disease; Structured interview; Visual hallucination

Indexed keywords

AGED; ARTICLE; AWARENESS; COGNITION; COGNITIVE DEFECT; CONTENT VALIDITY; CONTROLLED STUDY; CRITERION RELATED VALIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EMOTION; FACE VALIDITY; FACIES; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; NORTH EAST VISUAL HALUCCINATIONS INTERVIEW; PATIENT ATTITUDE; PILOT STUDY; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SEMI STRUCTURED INTERVIEW; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; EDUCATIONAL STATUS; EMOTIONS; EYE DISEASES; FEMALE; GERIATRIC ASSESSMENT; HALLUCINATIONS; HUMANS; INTERNAL-EXTERNAL CONTROL; INTERVIEW, PSYCHOLOGICAL; LEWY BODY DISEASE; MALE; MIDDLE AGED; OBSERVER VARIATION; PSYCHOMETRICS; RECURRENCE; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 46849104824     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1965     Document Type: Article

References (35)

1. Aarsland D, Larsen JP, Karlsen K, et al. 1999. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 10: 866-874.
2. Aarsland D, Larsen JP, Tandberg E, et al. 2000. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 8: 938-942.
3. Allen NH, Gordon S, Hope T, et al. 1996. Manchester and Oxford Universities Scale for the Psychopathological Assessment of Dementia (MOUSEPAD). Br J Psychiatry 3: 293-307.
4. Anderson SW, Rizzo M. 1994. Hallucinations following occipital lobe damage: the pathological activation of visual representations. J Clin Exp Neuropsychol 5: 651-663.
5. Andrews C, Collerton D, Mosimann UP, et al. 2007. Emotional experiences and complex visual hallucinations. Psychology Specialists Working with Older People - Newsletter 1: 51-53.
6. Barnes J, Boubert L, Harris J, et al. 2003. Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia 5: 565-574.
7. Barnes J, David AS. 2001. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 6: 727-733.
8. Burn D, Emre M, McKeith I, et al. 2006. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Mov Disord 11: 1899-1907.
9. Collerton D, Dudley R. 2004. A cognitive behavioural framework for the treatment of distressing visual hallucinations in older people. Behavioural Cog Psychother 28: 1-13.
10. Collerton D, Perry E, McKeith I. 2005. Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations. Behav Brain Sci 6: 737-757.
11. Cummings JL, Mega M, Gray K, et al. 1994. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 12: 2308-2314.
12. Emre M, Aarsland D, Brown R, et al. 2007. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 12: 1689-1707.
13. Fenelon G, Mahieux F, Huon R, et al. 2000. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123: 733-745.
14. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 3: 189-198.
15. Goetz CG, Stebbins GT. 1993. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 11: 2227-2229.
16. Gupta M, Singh G, Khwaja GA, et al. 2004. Hallucinations in Parkinson's disease - a study of forty three patients. J Assoc Physicians India 52: 703-706.
17. Harding AJ, Broe GA, Halliday GM. 2002. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125: 391-403.
18. Horrax G. 1923. Visual hallucinations as a cerebral localising phenomenon, with especial reference to their occurrence in tumours of the temporal lobe. Arch Neurol Psychiatry 19: 532-547.
19. Lowe GR. 1973. The phenomenology of hallucinations as an aid to differential diagnosis. Br J Psychiatry 577: 621-633.
20. Manford M, Andermann F. 1998. Complex visual hallucinations. Clinical and neurobiological insights. Brain 121: 1819-1840.
21. Matsui H, Udaka F, Tamura A, et al. 2006. Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. J Geriatr Psychiatry Neurol 1: 36-40.
22. McKeith IG, Dickson DW, Lowe J, et al. 2005. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 12: 1863-1872.
23. McKeith IG, Rowan E, Askew K, et al. 2006. More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. Am J Geriatr Psychiatry 7: 582-588.
24. McKeith IG, Weshes KA, Perry E, et al. 2004. Hallucinations Predict Attentional Improvements with Rivastigmine in Dementia with Lewy Bodies. Dement Geriatr Cogn Disord 1: 94-100.
25. Menon GJ. 2005. Complex visual hallucinations in the visually impaired: a structured history-taking approach. Arch Ophthalmol 3: 349-355.
26. Miyasaki JM, Shannon K, Voon V, et al. 2006. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 7: 996-1002.
27. Mosimann UP, Rowan EN, Partington CE, et al. 2006. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies. Am J Geriatr Psychiatry 2: 153-160.
28. Nesher R, Nesher G, Epstein E, et al. 2001. Charles Bonnet syndrome in glaucoma patients with low vision. J Glaucoma 5: 396-400.
29. Ondo WG, Levy JK, Vuong KD, et al. 2002. Olanzapine treatment for dopaminergic-induced hallucinations. Mov Disord 5: 1031-1035.
30. Reisberg B, Borenstein J, Salob SP, et al. 1987. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 48: 9-15.
31. Santhouse AM, Howard RJ, Ffytche DH. 2000. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain 123: 2055-2064.
32. Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al. 1996. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 9004: 794-797.
33. Tiraboschi P, Salmon DP, Hansen LA, et al. 2006. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain 129: 729-735.
34. Weinberger LM. 1940. Visual hallucinations and their neurooptical correlates. Arch Ophthalmol 23: 166-199.
35. Williams DR, Lees AJ. 2005. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 10: 605-610.